111, Inc. partners with Chugai Pharma China Ltd to fast-track innovations in chronic disease management

CHINA – 111, Inc., a leading tech-enabled healthcare platform company dedicated to digitally connecting patients with medicine and healthcare services in China, has announced a strategic cooperation agreement with Chugai Pharma China Co., Ltd., to accelerate innovations in chronic disease management.

Chronic disease has become an epidemic. The vast majority of annual health-care spending is spent on treating diseases such as heart disease, cancer, diabetes, and obesity.

Nonetheless, despite trillions of dollars spent on management, chronic diseases persist.

The agreement will enable 111 and Chugai Pharma China to collaborate in the creation of a “Healthy China” by establishing a “SMART Healthcare City” concept through the use of digital drug distribution programs and expanding the accessibility of treatment programs through modern logistics.

111 is currently the first Chinese e-commerce company to have an omni-channel commercialization partnership with Chugai Pharma China.

These initiatives will provide patients with end-to-end innovative medical solutions while also strengthening chronic disease management.

To develop and implement a national medicine and Internet strategy, 111 will leverage its advantages in Internet technology, intelligent supply chain, omni-channel drug commercialization, and cloud service e-commerce.

Dr. YU Gang, Co-founder and Executive Chairman of 111, Yukimatsu Kunihiko, Chairman and General Manager of Chugai Pharma China, members of the media, and over 50 representatives from medical institutions, industry associations, and pharmaceutical companies attended the signing ceremony.

The ‘Healthy China 2030’ plan proposed by the Chinese government aims to provide equal access to quality healthcare to the public by 2030. In order to achieve this goal, chronic disease management will be a key factor for the entire healthcare system,” Mr. Yukimatsu stated

This new strategic partnership with 111 will significantly help answer that call, and this collaboration will be beneficial for bringing new, convenient and accessible medical solutions to more Chinese patients and their families.

Dr. Yu also expressed his views about the new partnership saying: “Its extensive knowledge and wealth of international experience will serve as significant assets as we work to achieve our mutual goal of providing patients with a full range of healthcare solutions. As we move forward in this partnership, 111 will be able to provide a variety of resources, technology and platform support for Chugai Pharma China.

Would you like to get regular updates of such news articles? Subscribe to our HealthCare Africa News, email newsletters, which provide the latest news insights from Africa and the World’s health, pharma and biotech industry. SUBSCRIBE HERE

Related posts

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.